Breakthroughs, discoveries, and DIY tips sent six days a week. Terms of Service and Privacy Policy. When Clostridium difficile was discovered in 1935, it was ...

Infection with the pathogen Clostridium difficile is a significant source of healthcare-associated infections and estimated to account for 12 percent of all HAIs in the U.S.1 C. diff infection is the ...

Please provide your email address to receive an email when new articles are posted on . Exposure to a contaminated nearly doubles a patient’s risk for hospital-onset C. difficile infection. This ...

In five different studies, researchers explored the impact of various factors on increasing rates of Clostridium difficile infection (C. difficile), such the substantial increase in antibiotic use due ...

Clostridioides difficile (C. difficile or C. diff) is a type of bacteria that causes a range of gastrointestinal symptoms, from mild diarrhoea to life-threatening colitis. It affects the colon, which ...

Scientists have successfully defeated a dangerous intestinal pathogen, Clostridium difficile, with a drug targeting its toxins rather than its life. C. difficile is responsible for more than 250,000 ...

The study of Clostridium difficile infection (CDI) continues to reveal intricate details of its pathogenesis, epidemiology and potential novel therapies. Research has elucidated how the bacterium, ...

Please provide your email address to receive an email when new articles are posted on . The Infectious Diseases Society of America and The Society for Healthcare Epidemiology of America, or SHEA, have ...

Data from the phase 3 study confirmed the lot consistency, immunogenicity, safety, and tolerability of a toxoid-based Clostridioides difficile vaccine. Neutralizing antibody responses 1 month after ...

It seemed to come out of nowhere — a virulent strain of bacteria called Clostridium difficile. It picked up that name because when it was first discovered, it was difficult to grow in the lab. C.